Cite

HARVARD Citation

    Tussey, L. et al. (2016). Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins. Open forum infectious diseases. p. . [Online]. 
  
Back to record